Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02306291 |
| Title | Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | GlycoMimetics Incorporated |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | IRL | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California, Davis Comprehensive Cancer Center | Sacramento | California | 95817 | United States | Details | |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | United States | Details | |
| University of Michigan, Ann Arbor | Ann Arbor | Michigan | 48109 | United States | Details | |
| University of Rochester | Rochester | New York | 14642 | United States | Details | |
| Cleveland Clinic | Cleveland | Ohio | 44195 | United States | Details | |
| University of Washington | Seattle | Washington | 98109 | United States | Details | |
| Princess Alexandra Hospital | Brisbane | Australia | Details | |||
| University Hospital Galway | Galway | Ireland | Details |